Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
9.63
-0.27 (-2.73%)
At close: Dec 5, 2025, 4:00 PM EST
10.50
+0.87 (9.03%)
After-hours: Dec 5, 2025, 7:23 PM EST
Tango Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Tango Therapeutics stock have an average target of 12.5, with a low estimate of 10 and a high estimate of 15. The average target predicts an increase of 29.80% from the current stock price of 9.63.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tango Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +55.76% | Dec 4, 2025 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 18, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $8 → $14 | Strong Buy | Maintains | $8 → $14 | +45.38% | Nov 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +24.61% | Oct 24, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $11 | Buy | Initiates | $11 | +14.23% | Aug 19, 2025 |
Financial Forecast
Revenue This Year
64.37M
from 42.07M
Increased by 53.01%
Revenue Next Year
16.90M
from 64.37M
Decreased by -73.75%
EPS This Year
-0.91
from -1.19
EPS Next Year
-1.24
from -0.91
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 70.8M | 70.8M | ||||
| Avg | 64.4M | 16.9M | ||||
| Low | 61.1M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 68.2% | 9.9% | ||||
| Avg | 53.0% | -73.8% | ||||
| Low | 45.3% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.86 | -1.18 | ||||
| Avg | -0.91 | -1.24 | ||||
| Low | -0.98 | -1.29 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.